| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
We tested the hypothesis that airway wall dimensions are important determinants for the mechanical properties of airways. Lung tissue was obtained from 31 smokers with different degrees of
chronic obstructive pulmonary disease (COPD) who were operated on for a solitary lung lesion. Segments of small airways (n = 35) were mounted on cannulas in an organ bath and inflated and deflated cyclically between +15 and
15 cm H2O. For each airway this was done at baseline, after
methacholine, and after isoprenaline. Specific compliance (sCdyn), specific hysteresis (s
), and pressure at which the airways collapsed (Pcol) were calculated from each recording. Airway wall dimensions were measured morphometrically. Lung function parameters of airflow obstruction were correlated to sCdyn, s
, and Pcol. At baseline, after methacholine, and after isoprenaline sCdyn was 0.059, 0.052, and 0.085 cm H2O
1, s
was 13.5, 12.9, and 7.1%, and Pcol was
3.4,
3.5, and
1.9 cm H2O,
respectively. Differences between sCdyn, s
, and Pcol after methacholine and after isoprenaline
were highly significant (p < 0.001). Of all dimensions studied, smooth muscle area, but not total wall
area, was the most important determinant for sCdyn and for s
after methacholine. Specific hysteresis at baseline correlated to residual volume as a fraction of total lung capacity (RV/TLC) (r = 0.5, p = 0.05) and, in the presence of methacholine, to FEV1/FVC (r =
0.68, p = 0.02) and RV/TLC (r = 0.5, p = 0.05). We conclude that, in this study, smooth muscle area and smooth muscle tone, but not total wall area, are determinants for compliance, hysteresis, and collapsibility of isolated airways obtained from smokers.
| |
INTRODUCTION |
|---|
|
|
|---|
In chronic obstructive pulmonary disease (COPD) airway inflammation is associated with increased airway wall thickness (1). This thickness is relatively more severe in peripheral airways than in central airways, and is more pronounced in patients with more severe airflow obstruction (1). Similar findings were obtained in patients who died with or from asthma (2, 3). Thickening of the airway wall as such has little effect on airway resistance (1). However, in combination with smooth muscle shortening it causes an important increase of airway resistance (4, 5). The extent to which the smooth muscle in airways of patients with COPD shortens will depend on the force it develops and on the load against which the smooth muscle has to contract. Increased smooth muscle force in COPD has been described by some investigators (6) but not by others (7). Isotonic shortening was decreased in airway muscle from patients with COPD compared with smokers without airflow obstruction (8). These findings suggest that in COPD the load on the bronchial smooth muscle might be increased. In fact, chronic airway inflammation is associated with deposition of fibrous tissue such as collagen and elastin within different compartments of the airway wall (9). This probably makes airways stiffer (i.e., less compliant) and increases the load against which the smooth muscle contracts. We hypothesize that airway wall thickness is an important determinant of the mechanical properties of airways and that reduced compliance makes the airways less collapsible and decreases their distensibility and hysteresis.
This study was undertaken to evaluate the relation between compliance, collapsibility, and hysteresis, on the one hand, and wall dimensions of human peripheral airway segments on the other hand. Therefore, we have developed an experimental model to study compliance, hysteresis, and collapsibility of isolated human small airway segments at baseline tone and after maximal contraction and relaxation of the airway smooth muscle.
| |
METHODS |
|---|
|
|
|---|
Study Population
Lung tissue was obtained from 31 patients who had a lobar resection
or pneumonectomy for a peripheral lung lesion. These patients were
mostly smokers and were classified as "COPD" although one-third had a lung function within the normal range and, therefore, did not
strictly fulfil the American Thoracic Society criteria (14). Preoperative routine lung function was obtained from 27 of 31 patients. Forced
expiratory volume in one second (FEV1), forced vital capacity (FVC),
maximal flows at 50% (
max50) and 25% (
max25) of FVC, functional residual capacity (FRC), total lung capacity (TLC), residual
volume (RV), and RV as a fraction of TLC (RV/TLC% pred) are all
expressed as percentage of predicted (15). We used FEV1, expressed
as a percentage of FVC (FEV1/FVC), as an indicator of the severity of
airflow obstruction. Reversibility of bronchial obstruction was expressed as the absolute change in FEV1 as a percentage of the predicted FEV1 (
FEV1% pred) and as a percentage of the actual prebronchodilator FEV1 (
FEV1% ini). This protocol was approved by
the institutional review board for human studies.
Airway Segments
Lung tissue was collected and transported on ice in carbogenated
(5%CO2, 95% O2) Krebs-Henseleit buffer (composition in mM: NaCl
118, KCl 4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25, glucose
5.55). Peripheral airways were identified, cannulated with a thin plastic cannula, and dissected out with surrounding parenchyma. The airways were stored overnight in carbogenated Krebs-Henseleit buffer at
4° C. Next morning, parenchyma and blood vessels were removed
with the help of a dissection microscope (Stemi 2000; Carl Zeiss,
Oberkochen, Germany) and all side branches identified and ligated in
a watertight fashion. Airway segments at least 5 mm in length were selected for in vitro measurements. The internal diameters of the endings of the airways were estimated using the microscope by selecting
stainless steel cannulas (1, 1.5, 2, 3, or 4 mm) that most closely fitted
the diameter of the airway. Next, the airways were mounted in the organ bath on the cannulas in a watertight fashion. The airways were
perfused to test for patency and possible leaks. The length of the unstretched airway within the inner borders of the cannula sutures was
measured by a digital calipers (precision 0.1 mm). Next, we stretched
the airway to 140% of this length, that being the estimated length of
an airway close to TLC (16). At this length the airway remained patent at low transmural pressures and after contraction by methacholine. The volume (µl) of the airway was estimated by the formula
r2 l, where r is the average of the radius (mm) of the two cannulas and l is the length (mm) of the stretched airway.
Description of Experimental Setup
Figure 1 shows the experimental setup we used to measure the dynamic properties of the airway segments. It consists of a double-jacketed organ bath in which the cannulated airway segment was
mounted. The organ bath is filled with Krebs-Henseleit buffer at a
temperature of 37° C and continuously gassed with carbogen. Airway
segment and tubing are filled with buffer. All connecting tubing has a low compliance. Pressure was measured at both ends of the airway segment (Pprox and Pdist) using pressure transducers with a low compliance (143 PC ± 1 psi; Micro Switch, Freeport, IL). The compliance of
the whole system was 0.03 µl cm H2O
1. By means of a 3-way valve,
the airway segment can be connected to a gas-tight syringe mounted
on a computer-controlled, high-precision syringe pump (Harvard 22;
Harvard Apparatus Inc., South Natick, MA) for cyclic inflation and
deflation. Furthermore, the segment can be connected to a microplethysmograph that was designed to measure small volume displacements from or to the airway under isobaric conditions. Finally, the
segment can be connected to a reservoir filled with buffer for perfusion. The transmural pressure signals (Pprox and Pdist), the volume signal of the syringe pump, and the volume signal of the microplethysmograph (Pdiff) are all displayed on the computer monitor. The system
is servo-controlled, with the pressure signal from Pprox being used to
control the syringe pump.
|
Measurement Protocol
The Krebs buffer in the organ bath was replaced every 15 min throughout the experiments. Between tests the airway was perfused for 10 min. The speed of the pump for inflation and deflation was set at 8 times the estimated volume of the airway segment per minute. From a pilot study, we estimated that this would give a cycling rate between 1 and 4 cycles per minute.
Leak test. To test for a leak, the airway was inflated by the pump until a transmural pressure of 15 cm H2O was obtained. Next, the spontaneous rate of pressure drop of the segment within the first minute of inflation was recorded. In case of leakage it was either impossible to inflate the airway to 15 cm H2O, or its transmural pressure dropped rapidly to 0 cm H2O after inflation stopped.
Pressure-volume relation at baseline. Zero pressure of the proximal and distal valves was set by connecting the airway lumen to the atmosphere. The airway was then connected to the pump. Next, the airway was cyclically inflated and deflated between +15 and
15 cm
H2O using the computerized servo-controlled pump (Figure 2). The
upper pressure limit of 15 cm H2O was chosen because it corresponds
to the plateau of the pressure-volume curve of an air-filled system
(17). This transmural pressure is, therefore, likely to inflate the airway
to a level comparable to TLC. Three complete inflation-deflation cycles were done. After the third cycle, the airway was inflated to 15 cm
H2O at which point the pump automatically stopped. We recorded the
spontaneous pressure drop within 2 min to estimate maximal hysteresis and leak.
|
Isobaric contractility and relaxation. To monitor the contractile
response to methacholine or relaxation response to isoprenaline the
airway was connected to the microplethysmograph. The transmural pressure was set at 10 cm H2O by adjusting the height of the plethysmograph. Baseline volume displacement out of the plethysmograph
was recorded for 2 min before sufficient methacholine or isoprenaline
was added to the organ bath to give a final concentration of 10
4 M. The isobaric constriction or relaxation was recorded until no more
fluid was displaced into the plethysmograph or until the rate of fluid
displacement out of the plethysmograph became constant.
Pressure-volume relation in the presence of methacholine and isoprenaline. These were measured as described for baseline tone.
Isobaric relaxation. To monitor the relaxation response to isoprenaline the airway was connected to the microplethysmograph. The transmural pressure was set at 10 cm H2O by adjusting the height of the
plethysmograph. Baseline volume displacement out of the plethysmograph was recorded for 2 min before isoprenaline (10
4 M) was added
to the organ bath. The isobaric relaxation was recorded until the rate
of fluid displacement out of the plethysmograph became constant.
Pressure-volume relation after isoprenaline. This was measured as described for baseline.
Fixation. Finally, the airway was perfused with formalin (10%) from the distal end at a driving pressure of 10 cm H2O. The valve was closed as soon as formalin came out of the proximal valve and the Krebs buffer in the organ bath was quickly replaced with formalin. After fixation for 12 h at a transmural pressure of 10 cm H2O, the airway, including the ligatures at both ends, was gently pushed off the cannulas with forceps and stored in formalin until being processed for histology.
Compliance, Hysteresis, Collapsibility, and Contractility
Compliance (Cdyn, µl cm H2O
1) was calculated from the volume infused to inflate the airway from 0 to 15 cm H2O (Figure 2). The transition point of the pressure-volume curve where inflation changes to
deflation was selected as the upper pressure limit for the Cdyn calculation because it is least affected by hysteresis. Furthermore, it results
in the Cdyn of the stretched airway close to TLC where collagen is
likely to be an important mechanical determinant (18, 19). Therefore,
Cdyn should be sensitive to changes in airway collagen content. Hysteresis (
, µl cm H2O) was calculated as the area of the pressure-volume loop between 0 to 15 cm H2O. Collapsibility (Pcol, cm H2O) was
defined as the pressure of the deflation limb where the distal pressure
did not follow the proximal pressure, thus indicating closure of the airway lumen. Cdyn,
, and Pcol were calculated for each cycle. We analyzed Cdyn,
, and Pcol of the first cycle (Cdyn1,
1, and Pcol1) separately because we observed that these were always substantially
different from those of the subsequent cycles. The latter were similar
and were therefore taken together (Cdyn,
, and Pcol). The first cycle was excluded for analysis when it did not start exactly from 0 cm H2O
transmural pressure. Volume loops could not be analyzed for hysteresis in 11 airways where we used a high syringe volume and low speed
of the pump as this caused artifacts in the pressure-volume loops.
To normalize compliance for the volume of the airway segment,
Cdyn1 and Cdyn were divided by the volume of the airway segment as
calculated by morphometry (sCdyn1, sCdyn). Hysteresis was normalized as a percentage of the area of the maximal possible hysteresis (s
1, s
), which was defined as the product of volume infused and the
upper pressure limit (15 cm H2O). The spontaneous pressure drop
within 2 min after the last inflation was normalized for the inner surface area of the airway (internal perimeter times length) (specific
pressure drop, cm H2O mm
2). We calculated the maximal volume
displaced by the airway segment after methacholine (VM), or isoprenaline (VI). The response was negative when fluid moved out of the
contracting segment into the plethysmograph and positive when fluid
moved into the relaxing airway segment out of the plethysmograph.
The response was corrected for the rate of baseline fluid movement
before methacholine or isoprenaline was added. To correct for the
volume of the airway segment, VM and VI were expressed as the percentage of the volume of the airway segment as calculated from morphometry.
Airway Dimensions
To estimate airway wall dimensions and volume of the lumen, the segment was cut in cross section at both ends just inside the ligatures, decalcified, and embedded in paraffin in such a way that the airway segment could be cut in cross-section. A random starting point was selected within the first 0.5 mm at one end of the airway using a randomization table. Sections of 5 µm thickness were cut all the way through the airway with a microtome. Every 100th section (0.5 mm) was selected for morphometric analysis. We estimated that with this procedure we could obtain a reliable estimate of the mean airway wall dimensions. Sections were stained with a combined Gomori trichrome and elastin stain. This stain resulted in a good color contrast between airway wall structures. The measurements made are shown in Figure 3 and include: inner perimeter (Pi) and area of the lumen bounded by the respiratory epithelium (Ai); basement membrane perimeter (Pbm) and the area enclosed by this perimeter (Abm); the outer muscle perimeter (Pmo) and the area enclosed by this perimeter (Amo); the outer perimeter (Po) and the area enclosed by this perimeter (Ao); the area occupied by smooth muscle (WAm); and the area occupied by cartilage (WAcart).
|
Furthermore, we measured the height of the respiratory epithelium (Hepi) and the fraction of the Pbm covered by epithelium (Fepi). Hepi was measured as follows. First, a grid containing parallel sinusoids was superimposed over the computer image of the airway. When respiratory epithelium was present at the point where the sinusoid crossed the basement membrane, we measured the epithelial height by drawing a straight line perpendicular from the membrane to the top of the ciliary border. The length of this line was automatically computed. When respiratory epithelium was absent, a zero was scored for height. Second, Hepi was calculated for each airway section by computing the average of at least 15 epithelial height measurements around the lumen. Fepi was calculated by dividing the number of intersecting points through the basement membrane covered by respiratory epithelium with the total number of intersecting points, including the intersecting points at sites where the respiratory epithelium was absent. WAepi was calculated by multiplying Pbm by Hepi.
From these measurements we calculated the inner wall area including epithelium (WAi = Amo
Ai), inner wall area excluding epithelium (WAbm = Amo
Abm), outer wall area (WAo = Ao
Amo), and the total wall area (WAtot = Ao
Ai). This nomenclature was proposed for quantifying subdivisions in the bronchial wall (20).
Airway dimensions were measured using an automated image analysis system (KS 400; Kontron Electronic, Eching/Munich, Germany). Measurements of airway dimensions were performed by two observers (W.H. and H.d.B.). Each observer measured a different set of airway dimensions for all airways. The interobserver variability was assessed to compare airway dimensions of this study with a previous study in which we studied patients with variable degrees of airway wall thickening (1). This would give us evidence as to whether the patients we included in the present study had airway wall thickening in the same range as in previous studies. Both observers remeasured 15 randomly selected airways that were measured by the observer (H.T.) of the previous study. The intraobserver variability was assessed by remeasurement of 10 randomly selected airways with an interval of 2 mo.
Inflammatory changes of membranous airways were graded using the pictorial grading method of Wright and coworkers (21). The following indices were graded in the membranous bronchioles: inflammation, fibrosis, muscle hypertrophy, pigment deposition, goblet cell metaplasia, and squamous cell metaplasia. For each airway these six morphological indices were compared with pictorial reference standards with a score from 0 (normal) to 3 (most abnormal). Next the mean score for each morphological index for each individual specimen was calculated by summing the scores of the airways examined, divided by the number of airways examined. The average score for that variable was expressed as a percentage of maximal possible score. A total membranous airways disease score for each specimen was then calculated by summing the mean scores of the six morphological indices (maximal score: 6 × 100 = 600).
Statistical Analysis
The interobserver and intraobserver variability were calculated by expressing the difference of the first and the second measurement as a percentage of the average of both observations. This percentage was plotted against Pbm to detect systematic errors dependent upon airway size (22). For each airway and each airway wall dimension, we calculated the average and the standard error of the mean (SEM). To estimate the accuracy of our morphometric approach, we calculated for each airway the coefficient of variation of the mean using the formula (100% × SEM)/mean. In this formula, SEM relates to the variation between sections within a single airway. The relationships between each airway wall dimension (WAi, WAbm, WAo, WAt, WAm, WAcart, WAepi, Hepi, Fepi) and airway size (Pbm) were assessed using linear regression analysis. Previous studies found linear relationships between the square root of airway wall areas and airway size (1, 11, 23). We did a square root transformation on the airway areas of this study, again resulting in normal distributions of data.
We calculated the average specific compliance, specific hysteresis,
and collapsibility for the first cycle (sCdyn1, s
1, Pcol1) and for the
average of the second, third, and fourth cycle (sCdyn, s
, sPcol) for
all airway segments. Furthermore, we calculated the average specific
pressure drop. This was done for each of the three contractile conditions (baseline, methacholine, and isoprenaline). Repeated-measurements analysis of variance (ANOVA) was used to assess the overall
differences between the three conditions, followed by pairwise t tests
in case the former test was significant. We investigated the correlation
between the mechanical properties of the second, third, and fourth cycle (sCdyn, s
, Pcol) with airway wall dimensions (WAbm, WAo, WAt,
WAm, WAcart, WAepi, Fepi) using Spearman's correlation coefficient
(r). When a mechanical property correlated to various airway wall dimensions in univariate analysis, we studied their simultaneous effects
using multiple regression analysis. Data are expressed as mean ± standard deviation and range, unless indicated otherwise. p Values
given are two-sided. In view of the multiple comparisons, p values between 0.05 and 0.01 are considered as indicative only.
| |
RESULTS |
|---|
|
|
|---|
Study Population and Lung Function
Lung function and patient characteristics of the patients with
COPD are shown in Table 1. Out of the group of 27 COPD
patients with preoperative lung function test results, eight patients had no significant reduction of maximal expiratory airflow (FEV1/FVC > 70%), 12 patients had a mild reduction of
maximal expiratory airflow (FEV1/FVC 60 to 70%), and seven
patients had a more severe reduction (FEV1/FVC < 60% predicted). Increased residual volume [RV > RV(pred) + 2SD]
was present in five of the 18 patients who had body plethysmography. Reversibility of bronchial obstruction defined as
FEV1% pred > 15% and
FEV1% ini > 15% was not present in any of the 23 patients.
|
Airway Segments
We successfully completed all measurements of 35 cannulated
watertight airway segments. The diameter of the cannulas
used was 1.3 ± 0.39 (1 to 2) mm; the length of the stretched
airways was 14.2 ± 4.2 (6.7 to 21.2) mm. The median of the estimated volume of the segments was 30.7 (5.3 to 66.6) µl. Cycling frequency was 3.1 ± 1.9, 5 ± 5.4, and 1.8 ± 0.9 cycles
min
1 for baseline, methacholine, and isoprenaline, respectively.
At baseline, after methacholine and isoprenaline, 13, 13, and 2 out of the cycles, respectively, started above 0 cm H2O and
were therefore excluded for analysis.
Compliance, Hysteresis, and Collapsibility
The values for compliance and specific compliance (Cdyn and
sCdyn), hysteresis and specific hysteresis (
and s
), and collapsibility (Pcol) at baseline, after methacholine, and after isoprenaline are shown in Table 2 and in Figure 4.
|
|
On average, the specific compliance of the first cycle
(sCdyn1) was 13, 11, and 8% below the mean sCdyn of the
subsequent cycles for baseline (p < 0.001), methacholine (p = 0.03), and isoprenaline (p < 0.001), respectively (Figure 4).
The mean sCdyn after methacholine was 0.009 cm H2O
1 below that of baseline (p = 0.04). sCdyn after isoprenaline was 0.033 cm H2O
1 higher compared with baseline (p < 0.001)
and 0.042 cm H2O
1 higher compared with methacholine (p < 0.001). Expressed as percentages, these differences were 4, 101, and 197%, respectively.
The mean specific hysteresis of the first cycle was 34, 30, and 37% higher compared with s
of the subsequent cycles for
baseline, methacholine, and isoprenaline, respectively (p < 0.001) (Figure 4). The mean s
after methacholine was not significantly different from baseline. s
after isoprenaline was
6.8% lower compared with baseline (p < 0.001) and 7% lower
compared with methacholine (p < 0.001). Expressed as percentages, these differences were 9 and 39%, respectively.
The mean pressure drop within the 2 min after the last inflation of the compliance measurement was 6.5, 7.1, and 7.2 cm H2O for baseline, methacholine, and isoprenaline, respectively. The mean specific pressure drop for these conditions
was 0.009, 0.001, and 0.001 cm H2O mm
2. The differences between the three conditions were not significant.
The collapsibility of the first cycle was 0.6, 0.5, and 0.2 cm H2O below Pcol of the next cycles for baseline, methacholine, and isoprenaline, respectively (all p < 0.001) (Figure 4). Pcol after isoprenaline was 1.5 and 1.6 cm H2O above the values at baseline and with methacholine, respectively (both p < 0.001). Collapsibility at baseline and after methacholine were not significantly different. After maximal contraction, there were five airways that collapsed at pressures of 0 cm H2O or higher. After maximal relaxation, this number increased to nine. Pcol and sCdyn after methacholine were significantly correlated (r = 0.54, p = 0.001). In other words, the stiffer the airway after methacholine, the less collapsible it was.
The median fluid volume displaced by methacholine-induced
constriction was
9.4 (
41 to 10) µl or
37 (
103 to 119) %
of the estimated airway volume. For the relaxing airway after
isoprenaline these values were 5.9 (
7 to 46) µl or 31.4 (
14
to 58) %.
Airway Dimensions
The intra- and interobserver variability were well below 10% and 15%, respectively, for each of the airway wall dimensions. There was no systematic relationship between airway size (Pbm) and the intra- or interobserver variability for any variable. The mean coefficients of variation of the individual means for the airway dimensions for Pbm, WAbm, WAo, WAt, WAm, WAcart, Hepi, and Fepi were 4, 6, 8, 8, 10, 33, 12, and 13%, respectively. Characteristics of the airways are shown in Table 3. Highly significant (p < 0.002) linear relations were found between the square root of all airway wall areas and Pbm. There was a positive correlation between Hepi and Pbm (r = 0.43, p = 0.02); in other words, the epithelial layer in large airways was higher compared with small airways. Furthermore, there was a positive correlation between Fepi and Pbm (r = 0.39, p = 0.04), meaning there was more loss of epithelium in smaller airways. The average Hepi was 10.7 ± 6.3 (0.1 to 28.7) µm and Fepi was 53 ± 24 (1 to 96) %. The membranous airways disease score was 119 ± 40 (38 to 223).
|
Lung Function versus Compliance, Hysteresis, and Collapsibility
Specific hysteresis at baseline correlated to FEV1/FVC (r =
0.57, p = 0.06) and RV/TLC% pred (r = 0.5, p = 0.05). Hysteresis after methacholine correlated to FEV1/FVC (r =
0.68, p = 0.02), RV (r = 0.5, p = 0.05), and RV/TLC% pred
(r = 0.67, p = 0.007). There was no correlation between hysteresis and parameters of reversibility (
FEV1% pred and
FEV1% ini). Specific compliance and collapsibility did not
correlate to the parameters as mentioned previously.
Airway Dimensions versus Compliance, Hysteresis, and Collapsibility
Specific compliance (sCdyn) at baseline, after methacholine,
and after isoprenaline was independent of airway size (p = 0.2). Specific compliance at baseline correlated significantly to
the total wall area (WAt) (r =
0.35, p = 0.04) and outer wall
area (WAo) (r =
0.39, p = 0.02), not to other airway wall areas. Because the WAt components WAepi and WAbm did not
correlate to sCdyn, we conclude that of all factors studied
WAo is the most important component for sCdyn at baseline,
accounting for 15% of the variability. After methacholine,
sCdyn correlated negatively to the amount of smooth muscle
(WAm) (r =
0.37, p = 0.05) and to the area of epithelium
(WAepi) (r =
0.37, p = 0.05). Because of the strong correlations of WAm and WAepi, no conclusion about which of the two variables was more predictive for sCdyn could be obtained using multiple regression analysis. Specific compliance
after isoprenaline did not correlate to any of the airway dimensions. The difference between sCdyn after isoprenaline
and methacholine correlated significantly to WAm (r = 0.45, p = 0.02) but not to WAepi. The difference between sCdyn1
and sCdyn at baseline, after methacholine, and isoprenaline
did not correlate to any airway wall dimension.
Specific hysteresis (s
) at baseline was positively correlated
to WAt (r = 0.41, p = 0.04) and to WAm (r = 0.44, p = 0.04), but not to other airway wall dimensions (WAbm, WAcart,
WAepi). Because WAt and WAm were significantly correlated,
it was not possible to differentiate whether WAt or WAm was
the most predictive dimension for s
in a multiple regression
model. Specific hysteresis after methacholine correlated to
WAt (r = 0.54, p = 0.006), WAo (r = 0.52, p = 0.01), and
WAm (r = 0.6, p = 0.004), and to WAcart (r = 0.42, p = 0.04).
Multiple regression analysis showed that WAm was the only
remaining significant predictive dimension (p = 0.01). Specific
hysteresis after isoprenaline did not correlate to any of the airway dimensions. The difference between s
1 and s
at baseline, after methacholine, and after isoprenaline did not correlate to any airway wall dimension.
The specific pressure drop after the fourth inflation, indicating hysteresis and leak, was correlated negatively to all airway dimensions for baseline, after methacholine, and after isoprenaline (p < 0.01). Multiple regression analysis showed that at baseline, WAepi was the only remaining significant predictive dimension for the pressure drop. After methacholine, WAo was the only significant dimension (p = 0.04) determining the pressure drop. After isoprenaline, multiple regression analysis showed that WAo and WAepi were both predictive. Because of the strong correlations between the two, no conclusion about which variable was most predictive could be obtained. Thus, small airways with thinner epithelium and smaller outer airway wall area had a faster pressure drop after the final inflation.
Pcol of the airways at baseline, after methacholine, and after isoprenaline did not correlate to any of the airway wall dimensions (WAbm, WAo, WAt, WAm, WAcart, WAepi).
| |
DISCUSSION |
|---|
|
|
|---|
Chronic inflammation of the airways results in fibrous tissue deposition and thickening of the airway wall. We thought it likely that this remodeling makes the airway less compliant. Our results show that of the airway dimensions studied the bronchial smooth muscle area, not total wall area, is the most important determinant for airway compliance, hysteresis, and collapsibility.
Compliance
Airway compliance is an important predictor of airway diameter and lung compliance (26, 27). We expected that the inner and outer wall area of airways from smokers with varying degrees of airflow obstruction would be important determinants of sCdyn for a number of reasons. The inner and outer wall area correlated positively to inflammatory changes within the airway wall in smokers (1, 11). Furthermore, chronic airway inflammation is related to an increased amount of fibrous tissue within the airway wall (10, 11, 23) which is likely to make the airway stiffer. Though sCdyn correlated to the outer airway wall area at baseline tone, no correlation was present between the outer and inner wall area and sCdyn after maximal relaxation of bronchial smooth muscle tone. After maximal contraction of the smooth muscle, sCdyn decreased and smooth muscle area was the most important airway dimension for sCdyn. We believe that the weak correlation between WAm and sCdyn may well underestimate the importance of smooth muscle for airway compliance. Our measurement of WAm included not only smooth muscle cells but also connective tissue within the smooth muscle bundles, which increases the variability of the WAm measurement. Furthermore WAm is likely to be a poor estimate of the stress that can be generated by the smooth muscle as this is also dependent on the orientation of the muscle bundles in the airway wall, which was not assessed in our study. How can we explain that the inner and outer wall area did not correlate to sCdyn? It could be that the airways we investigated were not thickened by chronic inflammation. We think this is unlikely because the selection criteria for patients and lung tissue were the same as for previous studies (1, 11, 23). Furthermore, we investigated small airways, where inflammatory changes are known to be most severe (1). Finally, inflammation scores were within the same range as in a previous study (1) and these scores are known to correlate positively to the inner and outer airway wall area. The lack of correlation between inner and outer wall area and sCdyn could also be explained by assuming that these areas correlate poorly to the presence of structural components important for sCdyn such as collagen.
Specific compliance at baseline was two-thirds of sCdyn of the maximally relaxed airway. The initially high intrinsic contractile state could partly be an artifact related to our tissue preparation. Loss of epithelium was present in many of the airways we studied. Epithelium is a well-known source of bronchodilating substances (28) and its loss might therefore have increased smooth muscle tone. However, sCdyn at baseline did not correlate significantly to the percentage of the basement membrane covered by epithelium. Furthermore, sCdyn at baseline in our study was only slightly higher than other in vivo studies of human airways, taking into account differences in methodology (29). If there is a high smooth muscle tone in vivo too, then it is puzzling why none of the patients in our study and only one of 58 patients in a previous study showed reversibility after bronchodilatation (1). How can this discrepancy be explained? In our experimental setup airways were inflated by a mechanical pump. In vivo, airways are dilated by tethering forces of alveolar attachments in relation to breathing cycles. We speculate that in lungs of patients with COPD loss of alveolar attachments results in absence or incomplete dilation of segments or complete membranous airways, even after adequate relaxation of bronchial smooth muscle.
Hysteresis
Smooth muscle tone is known to be an important contributor
to hysteresis (33, 34). We found a significant decrease of s
with maximal relaxation compared with baseline and with the maximally contracted airways. However, we did not find a difference between s
at baseline and after maximal contraction
of the smooth muscle. This can be explained by the smaller increase in volume necessary to inflate a contracted airway to
the pressure limit of 15 cm H2O. Surprisingly, a substantial
portion of the s
was not contributed by smooth muscle tone.
After maximal relaxation, mean s
was still 53% of baseline
s
. Hysteresis of lung tissue is related to four different mechanisms: kinetics of cross-bridge attachment-detachment, kinetics related to the surface film, kinetics of fiber-fiber networking within the connective tissue matrix, and the kinetics of
recruitment-derecruitment (35). For the s
of fluid-filled relaxed airway segments in our study kinetics of cross-bridge attachment-detachment, surface tension, and recruitment do
not play an important role. Therefore, it is likely that s
of relaxed airway segments originates within the connective tissue matrix of the airway wall.
At baseline, s
was correlated both to the smooth muscle
area and to total airway wall area. After maximal contraction
of the smooth muscle, its area was the single most important
airway wall dimension related to s
. After maximal relaxation,
the total wall area was not correlated to s
. These findings
suggest that the total wall area does not reflect changes in the
fibrous tissue composition which determines s
. A surprising
finding was that specific hysteresis at baseline and after methacholine correlated to in vivo lung function parameters of airflow obstruction. If not a false-positive finding, this might reflect the role of smooth muscle tone in the pathogenesis of
airflow obstruction in COPD.
Collapsibility
To our knowledge, this is the first study on the relation between collapsibility and airway dimensions of human small airways. Collapsibility was correlated to smooth muscle tone and not to any of the airway dimensions. Reduction of smooth muscle tone made the airway more compliant and more collapsible. Airways with the biggest change in compliance between the maximally contracted and maximally relaxed state also had the biggest change in collapsibility. Many airways collapsed at negative pressures close to 0 cm H2O or higher. In vivo these airways will depend on parenchymal recoil pressure to remain open. The use of bronchodilators in patients might therefore facilitate airway closure during expiration. The importance of smooth muscle tone for the collapsibility of large airways has been reported for different animal species (36- 39). We conclude that collapsibility of small airways will to an important degree depend on smooth muscle tone and parenchymal support.
Effects of Volume History
The mechanical characteristics of the first cycle were substantially different from the subsequent cycles. On the first cycle, airways were less compliant, had a greater hysteresis, and
were less collapsible compared with subsequent cycles. Similar
findings were obtained earlier in bronchi and tracheal strip
preparations from dogs (33, 40). In vivo, the effect of volume
history on compliance and hysteresis has been described for
normal subjects, asthmatics, and patients with COPD (41).
In the general population and in COPD patients a deep inhalation results in bronchodilatation (41, 44). In asthmatics deep
inhalation can result in bronchoconstriction or bronchodilatation. In COPD, this effect is reduced but still present after inhalation of bronchodilators (44). We found that the difference
in sCdyn and s
between the first and the subsequent cycles
persisted even after maximal relaxation by isoprenaline. We
therefore conclude that the effect of volume history on sCdyn and s
is not only related to smooth muscle tone but also to
connective tissue within the airway wall.
Conclusions
In this study smooth muscle area and tone, but not total wall area, were the most important morphological correlates for the dynamic properties of isolated airways from smokers. We showed that maximal bronchodilatation doubled compliance, reduced hysteresis, and increased collapsibility of airway segments independently of airway wall thickness. The volume history of the isolated airway segments had a substantial effect on compliance, hysteresis, and collapsibility even in the absence of smooth muscle tone.
It was striking that isolated airways showed considerable reversibility of bronchoconstriction whereas in vivo patients with COPD have very little reversibility of airflow obstruction after inhalation of bronchodilators (1, 45). We speculate that in patients with COPD loss of alveolar attachments is responsible for absence or incomplete dilatation of segments of membranous airways, even after effective relaxation of bronchial smooth muscle.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to H. A. W. M. Tiddens, Sophia Children's Hospital, Dr. Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands. E-mail: tiddens{at}alkg.azr.nl
(Received in original form September 2, 1997 and in revised form December 15, 1998).
Acknowledgments: The authors thank Alex Nigg for technical advice concerning morphometry, Julius de Vries for the development of the multichannel registration program and data analysis tools. We are indebted to the chest physicians, thoracic surgeons, and pathologists of the Academical Hospital Leiden, Leyenburg Hospital The Hague, Zuider Hospital, and Academical Hospital Rotterdam for their help in obtaining lung tissue specimens and lung function data.
Supported by research grants from the Dutch Asthma Fund (NAF 91.08).
| |
References |
|---|
|
|
|---|
1. Tiddens, H. A. W. M., P. D. Paré, J. C. Hogg, W. C. J. Hop, R. Lambert, and J. C. de Jongste. 1995. Cartilaginous airway dimensions and airflow obstruction in human lungs. Am. J. Respir. Crit. Care Med. 152: 260-266 [Abstract].
2. Bai, T. R.. 1990. Abnormalities in airway smooth muscle in fatal asthma. Am. Rev. Respir. Dis. 141: 552-557 [Medline].
3. Carroll, N., J. Elliot, A. Morton, and A. James. 1993. The structure of large and small airways in nonfatal and fatal asthma. Am. Rev. Respir. Dis. 147: 405-410 [Medline].
4. James, A. L., P. D. Paré, and J. C. Hogg. 1989. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 139: 242-246 [Medline].
5.
Lambert, R. K.,
B. R. Wiggs, and
K. Kuwano.
1993.
Functional significance of increased airway smooth muscle in asthma and COPD.
J.
Appl. Physiol.
74:
2771-2781
6. de Jongste, J. C., H. Mons, R. Block, I. L. Bonta, A. P. Fredriksz, and K. F. Kerrebijn. 1987. Increased in vitro histamine responses in human small airway smooth muscle from patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 135: 549-553 [Medline].
7. Black, J. L.. 1991. Pharmacology of airway smooth muscle in chronic obstructive pulmonary disease and in asthma [published erratum appears in Am. Rev. Respir. Dis. 1991 144(3, Pt. 1):733]. Am. Rev. Respir. Dis. 143: 1177-1181 [Medline].
8. de Jongste, J. C., H. Mons, I. L. Bonta, and K. F. Kerrebijn. 1989. Relaxation responses of airway smooth muscle from subjects with and without chronic bronchitis and airflow limitation. Pulm. Pharmacol. 2: 75-79 [Medline].
9. Mullen, J. B., J. L. Wright, B. R. Wiggs, P. D. Paré, and J. C. Hogg. 1985. Reassessment of inflammation of airways in chronic bronchitis. Br. Med. J. 291: 1235-1239 .
10. Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1: 520-524 [Medline].
11. Bosken, C. H., B. R. Wiggs, P. D. Paré, and J. C. Hogg. 1990. Small airway dimensions in smokers with obstruction to airflow. Am. Rev. Respir. Dis. 142: 563-570 [Medline].
12. Brewster, C. E., P. H. Howarth, R. Djukanovic, J. Wilson, S. T. Holgate, and W. R. Roche. 1990. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 3: 507-511 .
13. Wilson, J. W., and X. Li. 1997. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin. Exp. Allergy 27: 363-371 [Medline].
14. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136: 225-243 [Medline].
15. Quanjer, P. H., A. Dalhuijsen, and B. C. Zomeren. 1983. Summary equations of reference values. Bull. Europ. Physiopath. Resp. 19: 45-51 .
16.
Hughes, J. M.,
F. G. Hoppin Jr., and
J. Mead.
1972.
Effect of lung inflation on bronchial length and diameter in excised lungs.
J. Appl. Physiol.
32:
25-35
17.
Hughes, J. M.,
H. A. Jones, and
A. G. Wilson.
1975.
Bronchial hysteresis
in excised lungs.
J. Physiol.
249:
435-443
18. Karlinsky, J. B., G. L. Snider, C. Franzblau, P. J. Stone, and F. G. Hoppin Jr.. 1976. In vitro effects of elastase and collagenase on mechanical properties of hamster lungs. Am. Rev. Respir. Dis. 113: 769-777 [Medline].
19. Wilson, J. W., X. Li, and M. C. Pain. 1993. The lack of distensibility of asthmatic airways. Am. Rev. Respir. Dis. 148: 806-809 [Medline].
20.
Bai, A.,
D. H. Eidelman,
J. C. Hogg,
A. L. James,
R. K. Lambert,
M. S. Ludwig,
J. Martin,
D. M. McDonald,
W. A. Mitzner,
M. Okazawa,
R. J. Pack,
P. D. Paré,
R. R. Schellenberg,
H. A. W. M. Tiddens,
E. M. Wagner, and
D. Yager.
1994.
Proposed nomenclature for quantifying
subdivisions of the bronchial wall.
J. Appl. Physiol.
77:
1011-1014
21. Wright, J. L., M. Cosio, B. Wiggs, and J. C. Hogg. 1985. A morphologic grading scheme for membranous and respiratory bronchioles. Arch. Pathol. Lab. Med. 109: 163-165 [Medline].
22. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310 [Medline].
23. Kuwano, K., C. H. Bosken, P. D. Paré, T. R. Bai, B. R. Wiggs, and J. C. Hogg. 1993. Small airways dimensions in asthma and chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 148: 1220-1225 [Medline].
24. Tiddens, H. A. W. M., J. M. Bogaard, J. C. de Jongste, W. C. J. Hop, H. O. Coxson, and P. D. Paré. 1996. Physiological and morphological determinants of maximal expiratory flow in chronic obstructive lung disease. Eur. Respir. J. 9: 1785-1794 [Abstract].
25. Tiddens, H. A. W. M., L. P. Koopman, R. K. Lambert, W. M. Elliott, W. C. J. Hop, T. W. van den Mark, W. J. de Boer, and J. C. de Jongste. 1997. Airway wall dimensions and bronchial responsiveness in cystic fibrosis lungs. Erasmus University, Rotterdam, The Netherlands.
26.
Clay, T. P.,
J. M. Hughes, and
H. A. Jones.
1977.
Relationship between
intrapulmonary airway diameter and smooth muscle tone in excised
lungs.
J. Physiol.
273:
355-365
27.
Mitzner, W.,
S. Blosser,
D. Yager, and
E. Wagner.
1992.
Effect of bronchial smooth muscle contraction on lung compliance.
J. Appl. Physiol.
72:
158-167
28. Hulsmann, A. R., and J. C. De Jongste. 1996. Modulation of airway responsiveness by the airway epithelium in humans, putative mechanisms. Clin. Exp. Allergy 26: 1236-1242 [Medline].
29.
Tisi, G. M.,
V. D. Minh, and
P. J. Friedman.
1975.
In vivo dimensional
response of airways of different size to transpulmonary pressure.
J.
Appl. Physiol.
39:
23-29
30.
Prakash, U. B., and
R. E. Hyatt.
1978.
Static mechanical properties of
bronchi in normal excised human lungs.
J. Appl. Physiol.
45:
45-50
31.
Hahn, H. L.,
A. Watson,
A. G. Wilson, and
N. B. Pride.
1980.
Influence
of bronchomotor tone on airway dimensions and resistance in excised
dog lungs.
J. Appl. Physiol.
49:
270-278
32. Baier, H., S. Zarzecki, and A. Wanner. 1981. Influence of lung inflation on the cross-sectional area of central airways in normals and in patients with lung disease. Respiration 41: 145-154 [Medline].
33.
Sasaki, H., and
F. G. Hoppin Jr..
1979.
Hysteresis of contracted airway
smooth muscle.
J. Appl. Physiol.
47:
1251-1262
34.
Wang, Y. T.,
L. M. Thompson,
E. P. Ingenito, and
R. H. Ingram Jr..
1990.
Effects of increasing doses of beta-agonists on airway and parenchymal hysteresis.
J. Appl. Physiol.
68:
363-368
35.
Fredberg, J. J., and
D. Stamenovic.
1989.
On the imperfect elasticity of
lung tissue.
J. Appl. Physiol.
67:
2408-2419
36.
Olsen, C. R.,
A. E. Stevens, and
M. B. McIlroy.
1967.
Rigidity of trachea
and bronchi during muscular constriction.
J. Appl. Physiol.
23:
27-43
37.
Penn, R. B.,
M. R. Wolfson, and
T. H. Shaffer.
1988.
Effect of tracheal
smooth muscle tone on collapsibility of immature airways.
J. Appl.
Physiol.
65:
863-869
38. Okazawa, M., and P. D. Paré. 1994. Pressure area relationship of membranous airways in rabbit (abstract). Am. J. Respir. Crit. Care Med. 149: A770 .
39. McFawn, P. K., and H. W. Mitchell. 1997. Bronchial compliance and wall structure during development of the immature human and pig lung. Eur. Respir. J. 10: 27-34 [Abstract].
40.
Gunst, S. J..
1983.
Contractile force of canine airway smooth muscle during cyclical length changes.
J. Appl. Physiol.
55:
759-769
41. Sparrow, D., G. T. O'Connor, S. T. Weiss, D. DeMolles, and R. H. Ingram Jr.. 1997. Volume history effects and airway responsiveness in middle-aged and older men: the Normative Aging Study. Am. J. Respir. Crit. Care Med. 155: 888-892 [Abstract].
42. Wheatley, J. R., P. D. Paré, and L. A. Engel. 1989. Reversibility of induced bronchoconstriction by deep inspiration in asthmatic and normal subjects. Eur. Respir. J. 2: 331-339 [Abstract].
43. Lim, T. K., N. B. Pride, and R. H. Ingram Jr.. 1987. Effects of volume history during spontaneous and acutely induced air-flow obstruction in asthma. Am. Rev. Respir. Dis. 135: 591-596 [Medline].
44.
Fairshter, R. D..
1985.
Airway hysteresis in normal subjects and individuals with chronic airflow obstruction.
J. Appl. Physiol.
58:
1505-1510
45. Riess, A., B. Wiggs, L. Verburgt, J. L. Wright, J. C. Hogg, and P. D. Paré. 1996. Morphologic determinants of airway responsiveness in chronic smokers. Am. J. Respir. Crit. Care Med. 154: 1444-1449 [Abstract].
This article has been cited by other articles:
![]() |
J.-M. Tadie, P. Henno, I. Leroy, C. Danel, E. Naline, C. Faisy, M. Riquet, M. Levy, D. Israel-Biet, and C. Delclaux Role of nitric oxide synthase/arginase balance in bronchial reactivity in patients with chronic obstructive pulmonary disease Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L489 - L497. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Noble, P. K. McFawn, and H. W. Mitchell Responsiveness of the isolated airway during simulated deep inspirations: effect of airway smooth muscle stiffness and strain J Appl Physiol, September 1, 2007; 103(3): 787 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. James and S. Wenzel Clinical relevance of airway remodelling in airway diseases Eur. Respir. J., July 1, 2007; 30(1): 134 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. An, T. R. Bai, J. H. T. Bates, J. L. Black, R. H. Brown, V. Brusasco, P. Chitano, L. Deng, M. Dowell, D. H. Eidelman, et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma Eur. Respir. J., May 1, 2007; 29(5): 834 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kim, G. J. Criner, H. Y. Abdallah, J. P. Gaughan, S. Furukawa, and C. C. Solomides Small Airway Morphometry and Improvement in Pulmonary Function after Lung Volume Reduction Surgery Am. J. Respir. Crit. Care Med., January 1, 2005; 171(1): 40 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kaminsky, C. G. Irvin, L. Lundblad, H. T. Moriya, S. Lang, J. Allen, T. Viola, M. Lynn, and J. H. T. Bates Oscillation mechanics of the human lung periphery in asthma J Appl Physiol, November 1, 2004; 97(5): 1849 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. McParland, P. D. Pare, P. R. A. Johnson, C. L. Armour, and J. L. Black Airway basement membrane perimeter in human airways is not a constant; potential implications for airway remodeling in asthma J Appl Physiol, August 1, 2004; 97(2): 556 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sera, H. Fujioka, H. Yokota, A. Makinouchi, R. Himeno, R. C. Schroter, and K. Tanishita Localized compliance of small airways in excised rat lungs using microfocal X-ray computed tomography J Appl Physiol, May 1, 2004; 96(5): 1665 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Hofhuis, E C van der Wiel, H A W M Tiddens, G Brinkhorst, W P J Holland, J C de Jongste, and P J F M Merkus Bronchodilation in infants with malacia or recurrent wheeze Arch. Dis. Child., March 1, 2003; 88(3): 246 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hofhuis, M. W. A. Huysman, E. C. van der Wiel, W. P. J. Holland, W. C. J. Hop, G. Brinkhorst, J. C. de Jongste, and P. J. F. M. Merkus Worsening of V'maxFRC in Infants with Chronic Lung Disease in the First Year of Life: A More Favorable Outcome after High-Frequency Oscillation Ventilation Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): 1539 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. TIDDENS, |